相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hsp70 in cancer: A double agent in the battle between survival and death
Mehdi A. Vostakolaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Inhibitors of HSP90 in melanoma
Aleksandra Mielczarek-Lewandowska et al.
APOPTOSIS (2020)
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor models
Lucia Nappi et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2)
Rathi N. Pillai et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism
Balaji Ramkumar et al.
MITOCHONDRION (2020)
Heat shock proteins as a new, promising target of multiple myeloma therapy
Sebastian Grosicki et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Heat Shock Proteins: Agents of Cancer Development and Therapeutic Targets in Anti-Cancer Therapy
Chul Won Yun et al.
CELLS (2020)
Heat shock proteins as biomarkers of lung cancer
Sonam Mittal et al.
CANCER BIOLOGY & THERAPY (2020)
Significance of unphosphorylated and phosphorylated heat shock protein 27 as a prognostic biomarker in pancreatic ductal adenocarcinoma
Richard Drexler et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Mimetic Heat Shock Protein Mediated Immune Process to Enhance Cancer Immunotherapy
Xue Li et al.
NANO LETTERS (2020)
HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity
Thomas L. Prince et al.
CELLS (2020)
The Association Between Heat-Shock Protein Polymorphisms and Prognosis in Lung Cancer Patients Treated With Platinum-Based Chemotherapy
Ting Zou et al.
FRONTIERS IN PHARMACOLOGY (2020)
Heat Shock Protein 60 in Hepatocellular Carcinoma: Insights and Perspectives
Abdullah Hoter et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Anticancer Attributes of Cantharidin: Involved Molecular Mechanisms and Pathways
Faiza Naz et al.
MOLECULES (2020)
Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer
Tong Lin et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Molecular Chaperones: Molecular Assembly Line Brings Metabolism and Immunity in Shape
Haoxin Zhao et al.
METABOLITES (2020)
Artesunate, as a HSP70 ATPase activity inhibitor, induces apoptosis in breast cancer cells
Masoud Pirali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis
Juergen Thanner et al.
ONCOIMMUNOLOGY (2020)
Spotlight on 17-AAG as an Hsp90 inhibitor for molecular targeted cancer treatment
Sona Talaei et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Regulating glycolysis, the TLR4 signal pathway and expression of RBM3 in mouse liver in response to acute cold exposure
Hongzhao Shi et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2019)
Overexpression of HSP27 and HSP70 is associated with decreased survival among patients with esophageal adenocarcinoma
Henna K. Soderstrom et al.
WORLD JOURNAL OF CLINICAL CASES (2019)
Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
Eisuke Kurihara et al.
ANTICANCER RESEARCH (2019)
Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress
Toshiki Kijima et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
pH-activated heat shock protein inhibition and radical generation enhanced NIR luminescence imaging-guided photothermal tumour ablation
Shuang Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells
Ruifang Teng et al.
REDOX BIOLOGY (2019)
Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion
Eman A. Taha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities
Abdullah Hoter et al.
CANCERS (2019)
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard et al.
FRONTIERS IN ONCOLOGY (2019)
Hsp60 and IL-8 axis promotes apoptosis resistance in cancer
Sandeep Kumar et al.
BRITISH JOURNAL OF CANCER (2019)
HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer
Jianying Guo et al.
SCIENTIFIC REPORTS (2019)
HSF1 as a Cancer Biomarker and Therapeutic Target
Richard L. Carpenter et al.
CURRENT CANCER DRUG TARGETS (2019)
Heat Shock Proteins in Cancer Immunotherapy
Jugal Kishore Das et al.
JOURNAL OF ONCOLOGY (2019)
Tumor tissue hnRNP M and HSP 90a as potential predictors of disease-specific mortality in patients with early-stage cutaneous head and neck melanoma: A proteomics-based study
Andro Ko�ec et al.
Oncotarget (2019)
Dorsomorphin induces cancer cell apoptosis and sensitizes cancer cells to HSP90 and proteasome inhibitors by reducing nuclear heat shock factor 1 levels
Na Li et al.
CANCER BIOLOGY & MEDICINE (2019)
Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer
Maxim Shevtsov et al.
FRONTIERS IN IMMUNOLOGY (2019)
Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy
Janice M. Santiago-O'Farrill et al.
ONCOTARGET (2018)
Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer
Yingji Jin et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art
Hassan Mellatyar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells
Alexandra Canonici et al.
INVESTIGATIONAL NEW DRUGS (2018)
Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients
Tao Wan et al.
ONCOTARGETS AND THERAPY (2018)
TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor
Danilo Swann Matassa et al.
GENES (2018)
Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer
Jasleen Saini et al.
CURRENT DRUG TARGETS (2018)
Circulating Heat Shock Protein 70 Is a Novel Biomarker for Early Diagnosis of Lung Cancer
Tielong Tang et al.
DISEASE MARKERS (2018)
The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease
Abdullah Hoter et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Subcellular Hsp70 Inhibitors Promote Cancer Cell Death via Different Mechanisms
Sang-Hyun Park et al.
CELL CHEMICAL BIOLOGY (2018)
Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70
Yang Zhou et al.
ONCOLOGY REPORTS (2017)
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Suman Chatterjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma
Jing Meng et al.
MOLECULAR CANCER (2017)
HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma
Qiuran Xu et al.
MOLECULAR CANCER (2017)
Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF
John D. Konda et al.
MOLECULAR ONCOLOGY (2017)
New inhibitor targeting human transcription factor HSF1: effects on the heat shock response and tumor cell survival
Nuria Vilaboa et al.
NUCLEIC ACIDS RESEARCH (2017)
Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis
J. H. Lee et al.
ONCOGENE (2017)
HSP90 stabilizes B-cell receptor kinases in a multi-client interactome: PU-H71 induces CLL apoptosis in a cytoprotective microenvironment
A. Guo et al.
ONCOGENE (2017)
Heat Shock Proteins and Cancer
Jianming Wu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Overexpression of heat-shock factor 1 is associated with a poor prognosis in esophageal squamous cell carcinoma
Yukiko Tsukao et al.
ONCOLOGY LETTERS (2017)
Vitexin confers HSF-1 mediated autophagic cell death by activating JNK and ApoL1 in colorectal carcinoma cells
Monika Bhardwaj et al.
ONCOTARGET (2017)
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models
Shu-Fu Lin et al.
ONCOTARGET (2017)
Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27
Kazuyo Yasuda et al.
ONCOTARGET (2017)
Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells
Christopher D. Zahm et al.
CANCER IMMUNOLOGY RESEARCH (2017)
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Rachel E. Lackie et al.
FRONTIERS IN NEUROSCIENCE (2017)
Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient's survival
Baowei Sheng et al.
SCIENTIFIC REPORTS (2017)
HSP90 inhibitor NVP-AUY922 induces cell apoptosis by disruption of the survivin in papillary thyroid carcinoma cells
Jinhao Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells
Xi Chen et al.
MOLECULAR MEDICINE REPORTS (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells
Chang-Nim Im
CELL STRESS & CHAPERONES (2016)
Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer
Francesca Rappa et al.
CELL STRESS & CHAPERONES (2016)
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Haidan Jin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Quercetin sensitizes glioblastoma to t-AUCB by dual inhibition of Hsp27 and COX-2 in vitro and in vivo
Junyang Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Quercetin blocks t-AUCB-induced autophagy by Hsp27 and Atg7 inhibition in glioblastoma cells in vitro
Junyang Li et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Imaging metabolic heterogeneity in cancer
Debanti Sengupta et al.
MOLECULAR CANCER (2016)
Dietary flavonoid fisetin for cancer prevention and treatment
Rahul K. Lall et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Heat Shock Proteins Promote Cancer: It's a Protection Racket
Stuart K. Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
HSF1 Guardian of Proteostasis in Cancer
Chengkai Dai et al.
TRENDS IN CELL BIOLOGY (2016)
Upregulation of HSF1 in estrogen receptor positive breast cancer
Yesim Goekmen-Polar et al.
ONCOTARGET (2016)
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer
Linda Kinzel et al.
ONCOTARGET (2016)
HSP27 and 70 expression in thymic epithelial tumors and benign thymic alterations: diagnostic, prognostic and physiologic implications
S. Janik et al.
SCIENTIFIC REPORTS (2016)
Down-regulation of HSP60 Suppresses the Proliferation of Glioblastoma Cells via the ROS/AMPK/mTOR Pathway
Haiping Tang et al.
SCIENTIFIC REPORTS (2016)
Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery
Claudia Campanella et al.
CANCER (2015)
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors
Johanna C. Bendell et al.
CANCER INVESTIGATION (2015)
Fisetin, a dietary flavonoid, induces apoptosis of cancer cells by inhibiting HSF1 activity through blocking its binding to the hsp70 promoter
Joo Ae Kim et al.
CARCINOGENESIS (2015)
Small heat shock protein 20 (Hsp20) facilitates nuclear import of protein kinase D 1 (PKD1) during cardiac hypertrophy
Yuan Yan Sin et al.
CELL COMMUNICATION AND SIGNALING (2015)
A First Line of Stress Defense: Small Heat Shock Proteins and Their Function in Protein Homeostasis
Martin Haslbeck et al.
JOURNAL OF MOLECULAR BIOLOGY (2015)
Cell surface GRP78: A potential marker of good prognosis and response to chemotherapy in breast cancer
Rinat Yerushalmi et al.
ONCOLOGY LETTERS (2015)
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial
Hanno M. Specht et al.
FRONTIERS IN IMMUNOLOGY (2015)
Heat Shock Protein 90 Promotes Epithelial to Mesenchymal Transition, Invasion, and Migration in Colorectal Cancer
Ganji Purnachandra Nagaraju et al.
MOLECULAR CARCINOGENESIS (2015)
Hsp70 in cancer: back to the future
M. Y. Sherman et al.
ONCOGENE (2015)
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors
H. Engerud et al.
BRITISH JOURNAL OF CANCER (2014)
Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma
Rong Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Validation of Heat Shock Protein 70 as a Tumor-Specific Biomarker for Monitoring the Outcome of Radiation Therapy in Tumor Mouse Models
Christine Bayer et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
Suqin He et al.
INVESTIGATIONAL NEW DRUGS (2014)
2,4-Bis(4-hydroxybenzyl)phenol Inhibits Heat Shock Transcription Factor 1 and Sensitizes Lung Cancer Cells to Conventional Anticancer Modalities
Taesook Yoon et al.
JOURNAL OF NATURAL PRODUCTS (2014)
mTOR Inhibition Potentiates HSP90 Inhibitor Activity via Cessation of HSP Synthesis
Jaime Acquaviva et al.
MOLECULAR CANCER RESEARCH (2014)
Heat-shock protein peptide complex-96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
HSP-90 inhibitor ganetespib is synergistic with doxorubicin in small cell lung cancer
C-H Lai et al.
ONCOGENE (2014)
Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer
Liang Ma et al.
ONCOLOGY REPORTS (2014)
Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?
M. Zhao et al.
TUMOR BIOLOGY (2014)
Targeting Aerobic Glycolysis and HIF-1α Expression Enhance Imiquimod-induced Apoptosis in Cancer Cells
Shi-Wei Huang et al.
ONCOTARGET (2014)
HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy
Ganji Purnachandra Nagaraju et al.
ONCOTARGET (2014)
Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression
Eric A. Voll et al.
ONCOTARGET (2014)
Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
Mathias Gehrmann et al.
FRONTIERS IN IMMUNOLOGY (2014)
Heat shock protein 27 phosphorylation state is associated with cancer progression
Maria Katsogiannou et al.
FRONTIERS IN GENETICS (2014)
Hsp90-a potential prognostic marker in CML
Marketa Zackova et al.
BLOOD CELLS MOLECULES AND DISEASES (2013)
Hsp90 Inhibitors as Anti-Cancer Agents, from Basic Discoveries to Clinical Development
Shiro Soga et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Heat-shock proteins as dendritic cell-targeting vaccines - getting warmer
Shaun McNulty et al.
IMMUNOLOGY (2013)
Expression of heat shock proteins in medulloblastoma Laboratory investigation
George A. Alexiou et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2013)
The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity
I. Paul et al.
ONCOGENE (2013)
Targeting HSF1 sensitizes cancer cells to HSP90 inhibition
Yaoyu Chen et al.
ONCOTARGET (2013)
Recent updates on the development of ganetespib as a Hsp90 inhibitor
Hyun Kyung Choi et al.
ARCHIVES OF PHARMACAL RESEARCH (2012)
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M. Gartner et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Aparna Rao et al.
CANCER RESEARCH (2012)
Proteomic investigation of anti-tumor activities exerted by sinularin against A2058 melanoma cells
Tzu-Rong Su et al.
ELECTROPHORESIS (2012)
Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death
Julie Acunzo et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
A Phase II trial of 17-allylamino, 17-demethoxygeldanamycin (17-AAG, tanespimycin) in patients with metastatic melanoma
Simon Pacey et al.
INVESTIGATIONAL NEW DRUGS (2012)
Heat shock protein 70 (Hsp70) inhibits oxidative phosphorylation and compensates ATP balance through enhanced glycolytic activity
Liangli Wang et al.
JOURNAL OF APPLIED PHYSIOLOGY (2012)
Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis
Man-Bo Cai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
Oddbjorn Straume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Alternative bacterial two-component small heat shock protein systems
Alexander Bepperling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
High HSP27 and HSP70 expression levels are independent adverse prognostic factors in primary resected colon cancer
Karina Bauer et al.
CELLULAR ONCOLOGY (2012)
Chemoresistance of Lung Cancer Stemlike Cells Depends on Activation of Hsp27
Han-Shui Hsu et al.
CANCER (2011)
HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on Trastuzumab
Shanu Modi et al.
CLINICAL CANCER RESEARCH (2011)
Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment
Hardik J. Patel et al.
EXPERT OPINION ON DRUG DISCOVERY (2011)
Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come
Ayesha Murshid et al.
EXPERT REVIEW OF VACCINES (2011)
RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients
Joerg-Christian Heinrich et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Heat Shock Protein-60 Expression was Significantly Correlated With the Prognosis of Lung Adenocarcinoma
Xin Xu et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
Sandro Santagata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons
Anna Wald et al.
VACCINE (2011)
The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60
K-A Chaiwatanasirikul et al.
CELL DEATH & DISEASE (2011)
Major heat shock protein Hsp72 controls oncogene-induced senescence
Michael Sherman
AGING, CANCER, AND AGE-RELATED DISEASES: COMMON MECHANISM? (2010)
Correlation between Clinicopathology and Expression of Heat Shock Protein 72 and Glycoprotein 96 in Human Esophageal Squamous Cell Carcinoma
Xiaoping Wang et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies
Shivaani Kummar et al.
EUROPEAN JOURNAL OF CANCER (2010)
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia
J. E. Lancet et al.
LEUKEMIA (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Drugging the heat shock factor 1 pathway Exploitation of the critical cancer cell dependence on the guardian of the proteome
Emmanuel de Billy et al.
CELL CYCLE (2009)
Guidelines for the nomenclature of the human heat shock proteins
Harm H. Kampinga et al.
CELL STRESS & CHAPERONES (2009)
Targeting Heat Shock Protein 90 with Non-Quinone Inhibitors: A Novel Chemotherapeutic Approach in Human Hepatocellular Carcinoma
Marco Breinig et al.
HEPATOLOGY (2009)
Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models
Eloisi Caldas-Lopes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: The C-100-21 study group
Alessandro Testori et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ
C. Desmetz et al.
JOURNAL OF PROTEOME RESEARCH (2008)
An adjuvant autologous therapeutic vaccine (HSPPC-96 vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentrel, open-label, randomised phase III trial
Christopher Wood et al.
LANCET (2008)
HSP90 as a marker of progression in melanoma
M. M. McCarthy et al.
ANNALS OF ONCOLOGY (2008)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Nicholas C. Denko
NATURE REVIEWS CANCER (2008)
Contribution of oncoproteomics to cancer biomarker discovery
William C. S. Cho
MOLECULAR CANCER (2007)
Heat shock protein 90: the cancer chaperone
Len Neckers
JOURNAL OF BIOSCIENCES (2007)
The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase -: art. no. 139
F Cappello et al.
BMC CANCER (2005)
Phase I pharmacokinetic and pharmacodynarnic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
U Banerji et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications
DR Ciocca et al.
CELL STRESS & CHAPERONES (2005)
Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma
A Ito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Development of Radicicol Analogues
Shiro Soga et al.
CURRENT CANCER DRUG TARGETS (2003)
Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone
P Workman
CANCER DETECTION AND PREVENTION (2002)
Role of the heat shock response and molecular chaperones in oncogenesis and cell death
C Jolly et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma
AT Hoang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
